Mediwelcome Healthcare Management & Technology Inc. Fundamental Analysis
Mediwelcome Healthcare Management & Technology Inc. Fundamental Analysis
Mediwelcome Healthcare Management & Technology Inc. (2159.HK) shows weak financial fundamentals with a PE ratio of 48.39, profit margin of 2.13%, and ROE of 11.38%. The company generates $0.5B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 46.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 2159.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak2159.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate2159.HK shows balanced valuation metrics.
Growth Score
Weak2159.HK faces weak or negative growth trends.
Financial Health Score
Excellent2159.HK maintains a strong and stable balance sheet.
Profitability Score
Weak2159.HK struggles to sustain strong margins.
Key Financial Metrics
Is 2159.HK Expensive or Cheap?
P/E Ratio
2159.HK trades at 48.39 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 2159.HK's PEG of 0.28 indicates potential undervaluation.
Price to Book
The market values Mediwelcome Healthcare Management & Technology Inc. at 3.33 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 151.10 times EBITDA. This signals the market has high growth expectations.
How Well Does 2159.HK Make Money?
Net Profit Margin
For every $100 in sales, Mediwelcome Healthcare Management & Technology Inc. keeps $2.13 as profit after all expenses.
Operating Margin
Core operations generate 0.39 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.38 in profit for every $100 of shareholder equity.
ROA
Mediwelcome Healthcare Management & Technology Inc. generates $5.24 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Mediwelcome Healthcare Management & Technology Inc. generates limited operating cash flow of $3.58M, signaling weaker underlying cash strength.
Free Cash Flow
Mediwelcome Healthcare Management & Technology Inc. generates weak or negative free cash flow of $3.15M, restricting financial flexibility.
FCF Per Share
Each share generates $0.01 in free cash annually.
FCF Yield
2159.HK converts 0.81% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
48.39
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.28
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.33
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.81
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.49
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.89
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.02
vs 25 benchmark
How 2159.HK Stacks Against Its Sector Peers
| Metric | 2159.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 48.39 | 29.15 | Worse (Expensive) |
| ROE | 11.38% | 438.00% | Weak |
| Net Margin | 2.13% | -11409.00% (disorted) | Weak |
| Debt/Equity | 0.49 | 0.78 | Strong (Low Leverage) |
| Current Ratio | 1.89 | 5.14 | Neutral |
| ROA | 5.24% | -21.00% (disorted) | Weak |
2159.HK outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Mediwelcome Healthcare Management & Technology Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation